Cette publication ne fait pas partie de la bibliothèque YouScribe
Elle est disponible uniquement à l'achat (la librairie de YouScribe)
Achetez pour : 201,29 € Lire un extrait


Format(s) : EPUB

avec DRM

Textbook of Hemophilia

560 pages

Textbook of Hemophilia, 3rd edition

Edited by
Christine A. Lee, MA, MD, DSc, FRCP, FRCPath, FRCOG
Emeritus Professor of Haemophilia, University of London, London, UK

Erik E. Berntorp, MD, PhD
Professor of Coagulation Medicine, Lund University
Malmö Centre for Thrombosis and Haemostasis, Skåne University Hospital, Malmö, Sweden

W. Keith Hoots, MD
Director, Division of Blood Diseases and Resources, National Heart, Lung and Blood Institute
National Institutes of Health, Bethesda, MD;
Professor of Pediatrics and Internal Medicine, University of Texas Medical School at Houston, Houston, TX, USA

Without doubt, Textbook of Hemophilia, 3rd edition is the definitive reference source on all aspects of haemophilia including diagnosis, management and treatment. Edited by three, world-renowned experts on haemophilia, this completely revised resource features chapters written by over 60 international contributors with international expertise in caring for haemophilia patients.

Textbook of Hemophilia, 3rd edition

  • Features eight new chapters, covering individualised dosing, vCJD and haemophilia, new drugs in the pipeline, and surgery in inhibitor patients
  • Presents new developments, such as gene therapy
  • Highlights controversial issues and provides advice for everyday clinical questions
  • Represents essential reading for all healthcare professionals involved in the care of those with haemophilia

 Titles of related interest

 Hemophilia and Hemostasis: A Case-Based Approach to Management, 2nd Edition

Ma, ISBN: 9780470659762

Current and Future Issues in Hemophilia Care

Rodriguez-Merchan, ISBN: 9780470670576


Voir plus Voir moins
The editors have included new authors and topics, and several chapters from second edition have been dropped. The overall organisation of the textbook has been changed in the light of changes of emphasis over the past 10 years. References have been restricted to create an overall succinct and comprehensive volume. 
A chapter on novel therapies in clinical trials or pre-clinical trials will be added at the time of going to press.  The editors have consolidated the gene therapy section from three to two chapters, and retitled the Section, The Future of Haemophilia Therapy.  The chapter on Old Age in Haemophilia has been extended to include more about survivorship with HCV/HIV and perioperative management (+/- anticoagulation in association with post-stent/cardiothoracic surgery following MI).
Two areas that particularly needed reorganisation and rewriting were Inhibitors
and Treatment to incorporate new products and future directions. Major new initiatives such as EUHASS have been incorporated. Furthermore, Ethical aspects of hemophilia care now merits a chapter on its own.